# Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)

> **NCT01308255** · PHASE4 · COMPLETED · sponsor: **University of Leeds** · enrollment: 112 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Methylprednisolone
- **DRUG:** Methotrexate
- **DIETARY_SUPPLEMENT:** Folic acid

## Key facts

- **NCT ID:** NCT01308255
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308255, "Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01308255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*